乳腺癌新辅助化疗的临床研究进展

Progress of clinical research of neoadjuvant chemotherapy for breast cancer

乳腺癌是全身性疾病，通过手术、放疗、化疗、内分泌等综合治疗可提高疗效。近年乳腺癌新辅助化疗（NCT）引起了肿瘤学界极大的兴趣，一系列的临床研究都希望这一疗法不但能提高保乳，而且能延长总生存期。现就NCT在乳腺癌治疗中的研究进展作一综述。

Breast cancer is a systemic disease, only through multidisciplinary treatment including surgery, radiotherapy, chemotherapy, endocrine, can we enhance its effectiveness. In recent years, neoadjuvant chemotherapy for breast cancer has aroused great interest in tumor academia. We hope that this therapy can not only improve breast conservation rate, but also extend the overall survival through a series of clinical studies. This review presents the research progress of neoadjuvant chemotherapy for breast cancer.